Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI).
The NHS has announced a review to investigate the training needs of NHS staff, so they have the skills to administer groundbreaking artificial intelligence and robotics-based treatments.